sulforaphane has been researched along with Pulmonary Hypertension in 3 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) is a natural isothiocyanate extracted from cruciferous vegetables with promising anti-inflammatory and anti-oxidative activities." | 5.91 | Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress. ( Cheng, K; Gong, M; Ji, Y; Li, J; Liu, L; Liu, Q; Pan, J; Pei, Y; Sun, J; Tang, Q; Wang, D; Wang, R; Wu, N; Yuan, Y; Zhang, C; Zheng, X, 2023) |
| " We recently demonstrated that sulforaphane (SFN) protected mice from developing pulmonary arterial hypertension (PAH) and right ventricular (RV) dysfunction by elevating cardiac Nrf2 expression and function." | 4.12 | Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice. ( Cai, J; Cai, L; Cathey, D; Huang, J; Kang, Y; Keller, BB; LeBlanc, AJ; Wang, S; Zhang, G, 2022) |
| "Sulforaphane (SFN) is a natural isothiocyanate extracted from cruciferous vegetables with promising anti-inflammatory and anti-oxidative activities." | 1.91 | Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress. ( Cheng, K; Gong, M; Ji, Y; Li, J; Liu, L; Liu, Q; Pan, J; Pei, Y; Sun, J; Tang, Q; Wang, D; Wang, R; Wu, N; Yuan, Y; Zhang, C; Zheng, X, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, G | 2 |
| Kang, Y | 2 |
| Cathey, D | 1 |
| LeBlanc, AJ | 1 |
| Cai, J | 2 |
| Cai, L | 2 |
| Wang, S | 2 |
| Huang, J | 2 |
| Keller, BB | 2 |
| Pan, J | 1 |
| Wang, R | 1 |
| Pei, Y | 1 |
| Wang, D | 1 |
| Wu, N | 1 |
| Ji, Y | 1 |
| Tang, Q | 1 |
| Liu, L | 1 |
| Cheng, K | 1 |
| Liu, Q | 1 |
| Sun, J | 1 |
| Gong, M | 1 |
| Zheng, X | 1 |
| Li, J | 1 |
| Zhang, C | 1 |
| Yuan, Y | 1 |
| Huang, EC | 1 |
3 other studies available for sulforaphane and Pulmonary Hypertension
| Article | Year |
|---|---|
Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
Topics: Animals; Hypertension, Pulmonary; Isothiocyanates; Male; Mice; Mice, Knockout; NF-E2-Related Factor | 2022 |
Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress.
Topics: Animals; Cell Proliferation; Endothelial Cells; Hypertension, Pulmonary; Hypoxia; Inflammation; Isot | 2023 |
Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Topics: Animals; Anti-Inflammatory Agents; Hypertension, Pulmonary; Isothiocyanates; Male; Mice; Mice, Inbre | 2020 |